Summary
Estimations of Michaelis-Menten constants Km and Amax (product of Vmax and pulmonary microvascular plasma volume) of pulmonary, endothelial-bound angiotensin converting enzyme (ACE) for the synthetic substrate 3H-Benzoyl-Phe-Ala-Pro (BPAP) were performed in rabbits, in vivo, utilizing indicator dilution techniques. The animals were conscious and equipped with permanent right atrial and left carotid catheters. For each determination of Km and Amax, two consecutive bolus injections of BPAP were given into the right atrial catheter, the first containing 0.1 and the second 1622 nmol of substrate, producing first order and mixed order substrate concentrations, respectively, in the pulmonary circulation. Arterial blood was withdrawn at 0.7 sec intervals for 15 sec after each injection and from the family of substrate concentrations thus created (usually 14–20) and resulting range of substrate utilization (10–90%), Km and Amax values were calculated utilizing the Lineweaver-Burk, Eadie-Scatchard, Woolf-Augustinsson-Hofstee or Hanes-Woolf transformations of the integrated Henri-Michaelis-Menten equation. All four methods produced similar values of Km (10–12 μM), Amax (6–7 μmol/min) and Amax/Km (600–720 ml/min); however, linear regression analysis of data from the Hanes-Woolf transformation resulted in a higher correlation coefficient (0.96 vs 0.86-0.88 for the other three methods). Values for the kinetic constants reported here were similar to those previously reported in anesthetized rabbits utilizing the Woolf-Augustinsson-Hofstee transformation, but higher than those reported for purified rabbit lung ACE, in vitro.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J. D. Catravas and R. E. White, Kinetics of angiotensin converting enzyme and 5-nucleotidase, in vivo, J. Appl. Physiol. 57: 1173–1181 (1984).
R. E. Howell, R. Moalli, and C. N. Gillis, Analysis of rabbit pulmonary angiotensin converting enzyme kinetics, in vivo, J. Pharmacol. Exp. Ther. 228: 154–160 (1984).
B. R. Pitt and G. Lister, Kinetics of pulmonary angiotensin converting enzyme activity in conscious developing lambs, J. Appl. Physiol. 57: 1158–1166 (1984).
J. H. Linehan and C. A. Dawson, A kinetic model of prostaglandin metabolism in the lung, J. Appl. Physiol. 47: 411–424 (1979).
I. H. Segal, “Enzyme Kinetics,” Wiley, New York (1975).
J. W. Ryan, L. C. Martin, A. Chung, and G. Pena, Mammalian inhibitors of angiotensin converting enzyme (Kininase II), Adv. Exp. Med. Biol. 120B: 599–606 (1979).
J. W. Ryan, Assay of peptidase and protease enzymes, in vivo, Biochem. Pharmacol. 32: 2127–2137 (1983).
J. W. Ryan, Angiotensin I converting enzyme (Kininase II) peptidyl-dipeptide hydrolase EC 3.4.15.1, in: “Methods of Enzymatic Analysis, Vol. 5, ” H. O. Bergmeyer, ed., Verlag Chemie GmbH, Weinheim, Germany (1984).
J. S. Lazo, J. D. Catravas, and C. N. Gillis, Reduction in rabbit serum and pulmonary angiotensin converting enzyme activity after subacute bleomycin treatment, Biochem. Pharmacol. 18: 2577–2584 (1981).
J. J. Lanzillo and B. L. Fanburg, Development of competitive enzyme immunoassays for human serum angiotensin-1-converting enzyme: A comparison of four assay configurations, Anal. Biochem. 126: 156–164 (1982).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Catravas, J.D. (1986). Michaelis-Menten Kinetics of Pulmonary Endothelial Angiotensin Converting Enzyme in the Conscious Rabbit. In: Greenbaum, L.M., Margolius, H.S. (eds) Kinins IV. Advances in Experimental Medicine and Biology, vol 198A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5143-6_60
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5143-6_60
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5145-0
Online ISBN: 978-1-4684-5143-6
eBook Packages: Springer Book Archive